Free Trial

Tectonic Therapeutic (TECX) Stock Forecast & Price Target

Tectonic Therapeutic logo
$40.45 -2.81 (-6.50%)
(As of 11/15/2024 ET)

Tectonic Therapeutic - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
5

Based on 5 Wall Street analysts who have issued ratings for Tectonic Therapeutic in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 4 have given a buy rating, and 1 has given a strong buy rating for TECX.

Consensus Price Target

$74.67
84.59% Upside
According to the 5 analysts' twelve-month price targets for Tectonic Therapeutic, the average price target is $74.67. The highest price target for TECX is $79.00, while the lowest price target for TECX is $69.00. The average price target represents a forecasted upside of 84.59% from the current price of $40.45.

TECX Analyst Ratings Over Time

TypeCurrent Forecast
11/17/23 to 11/16/24
1 Month Ago
10/18/23 to 10/17/24
3 Months Ago
8/19/23 to 8/18/24
1 Year Ago
11/17/22 to 11/17/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
N/A
Buy
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
N/A
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$74.67$60.00$62.50N/A
Forecasted Upside84.59% Upside66.99% Upside267.22% UpsideN/A
Consensus Rating
Buy
Buy
Buy
N/A

TECX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TECX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Tectonic Therapeutic Stock vs. The Competition

TypeTectonic TherapeuticMedical CompaniesS&P 500
Consensus Rating Score
3.20
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside84.59% Upside28,534.31% Upside9.86% Upside
News Sentiment Rating
Positive News

See Recent TECX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/12/2024Wells Fargo & Company
3 of 5 stars
T. Fauth
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$55.00 ➝ $79.00+71.48%
11/11/2024Leerink Partners
1 of 5 stars
 Boost TargetOutperform ➝ Outperform$49.00 ➝ $69.00+49.77%
7/24/2024Leerink Partnrs
5 of 5 stars
D. Risinger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/26/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Y. Rahimi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$76.00+375.89%
6/24/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:40 PM ET.


TECX Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Tectonic Therapeutic is $74.67, with a high forecast of $79.00 and a low forecast of $69.00.

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tectonic Therapeutic in the last twelve months. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TECX shares.

According to analysts, Tectonic Therapeutic's stock has a predicted upside of 84.59% based on their 12-month stock forecasts.

Tectonic Therapeutic has been rated by research analysts at Leerink Partners, and Wells Fargo & Company in the past 90 days.

Analysts like Tectonic Therapeutic more than other "medical" companies. The consensus rating for Tectonic Therapeutic is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TECX compares to other companies.


This page (NASDAQ:TECX) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners